RJFSA
WST icon

Raymond James Financial Services Advisors’s West Pharmaceutical WST Stock Holding History

Raymond James Financial Services Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.09M Sell
3,638
-95
-3% -$29.1K ﹤0.01% 2103
2024
Q2 		$1.23M Buy
3,733
+42
+1% +$14.8K ﹤0.01% 1956
2024
Q1 		$1.46M Buy
3,691
+84
+2% +$31.1K ﹤0.01% 1836
2023
Q4 		$1.27M Sell
3,607
-428
-11% -$151K ﹤0.01% 1846
2023
Q3 		$1.51M Buy
4,035
+689
+21% +$266K ﹤0.01% 1665
2023
Q2 		$1.28M Sell
3,346
-20
-0.6% -$7.14K ﹤0.01% 1783
2023
Q1 		$1.17M Buy
3,366
+382
+13% +$112K ﹤0.01% 1812
2022
Q4 		$702K Buy
2,984
+967
+48% +$229K ﹤0.01% 2072
2022
Q3 		$496K Sell
2,017
-531
-21% -$162K ﹤0.01% 2254
2022
Q2 		$771K Sell
2,548
-2,458
-49% -$800K ﹤0.01% 2004
2022
Q1 		$2.06M Buy
5,006
+1,134
+29% +$444K ﹤0.01% 1469
2021
Q4 		$1.82M Sell
3,872
-2,533
-40% -$1.09M ﹤0.01% 1601
2021
Q3 		$2.72M Buy
6,405
+4,792
+297% +$2.02M 0.01% 1307
2021
Q2 		$579K Sell
1,613
-3,148
-66% -$1.04M ﹤0.01% 2281
2021
Q1 		$1.34M Sell
4,761
-493
-9% -$141K ﹤0.01% 1651
2020
Q4 		$1.49M Buy
5,254
+3,981
+313% +$1.12M ﹤0.01% 1469
2020
Q3 		$350K Buy
+1,273
New +$337K ﹤0.01% 2199

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial Services Advisors's WST Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its West Pharmaceutical (WST) stake by 2.5% in Q3 2024, selling an estimated $29.1K and leaving 3,638 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

Raymond James Financial Services Advisors first reported a position in WST in Q3 2020 and has held it in 17 quarters since. The position peaked at $2.72M in Q3 2021. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Raymond James Financial Services Advisors held 3,638 shares of West Pharmaceutical worth $1.09M as of Q3 2024.
  • Raymond James Financial Services Advisors sold 95 West Pharmaceutical shares in Q3 2024, an estimated $29.1K.
  • West Pharmaceutical made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2103 holding.
  • Raymond James Financial Services Advisors first reported a position in West Pharmaceutical in Q3 2020 and has held it in 17 quarters since.
  • Raymond James Financial Services Advisors's West Pharmaceutical position peaked at $2.72M in Q3 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.